Year: 2024
Type: article
Abstract: annabis use remains common in the United States.The rapidly changing landscape of cannabis regulatory policies may be contributing to these trends, although evidence remains mixed. 1 While studies are conflicted about the impact of recreational (RML) and medical (MML) marijuana laws on cannabis use, per se, there appears to be emerging support for an uptick in emergency department visits, traffic injuries and fatalities, and burgeoning cases of poisoning in toddlers and preschool-aged children, possibly due to increasing availability of edible forms of the drug.2,3 Beyond these immediate consequences of cannabis exposure and use lies a vast and concerning literature addressing elevated rates of mental health problems in individuals using cannabis.In particular, individuals with schizophrenia, psychotic disorders, and psychosis are considerably more likely to report chronic cannabis use and problems with cannabis compared to those without these mental health conditions.4 Similarly, rates of schizophrenia, psychotic disorders, and psychosis-like behaviors are overrepresented in individuals who use cannabis heavily compared to the general population.5 It has long been assumed that these associations, which The state of Missouri is now part of the national cannabis experiment.It is likely a good time for greater vigilance surrounding cannabis use, which should be routinely queried in medical settings, similar to alcohol and tobacco.
Source: PubMed
Authors: Emma C Johnson, Arpana Agrawal
Institution: Washington University in St. Louis
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4403557232